Common Oversights On Issuance Of Optionally Convertible Debentures (OCDs)

INTRODUCTION

Optionally Convertible Debentures (OCDs) have emerged as a popular instrument for raising funds in both domestic and cross-border transactions. They offer the flexibility of debt with the optionality of equity conversion, making them attractive to investors and promoters alike. However, their hybrid nature triggers compliance under multiple laws, including the Companies Act, 2013, FEMA Regulations, SEBI Regulations (for listed entities), and Income Tax provisions.

Despite their popularity, many companies (especially startups and unlisted public/private companies) make serious compliance errors during the issuance, management, and conversion of OCDs.

WHAT ARE OPTIONALLY CONVERTIBLE DEBENTURES?

As the name implies, optionally convertible debentures are a type of debt instrument that companies use to raise capital from investors. Unlike regular debentures, these provide investors with the option to convert them into equity shares at a later stage. The conversion price may be predetermined at the time of issuance or decided at the time of conversion. Until these debentures are either converted into shares or reach maturity, investors earn interest according to the terms set at issuance.

This article lists some of the most common mistakes observed in practice and offers tips to avoid them.

Incorrect Classification of OCDs under FEMA

• Mistake: Treating OCDs as pure debt instruments for foreign investment purposes.
• Explanation: Under FEMA, OCDs are classified as foreign direct investment (FDI) and not as external commercial borrowings (ECBs), provided they are issued by Indian companies to persons resident outside India and are convertible into equity.
• Tip: Ensure that OCDs are compliant with the FDI Policy and FEMA (Non-Debt Instruments) Rules, 2019. File Form FC-GPR post allotment within 30 days and include conversion terms in the instrument.

Non-Compliance with Companies Act Provisions

• Mistake: Failure to adhere to Sections 42 and 62 of the Companies Act, 2013 while issuing OCDs.
• Explanation: OCDs are generally issued as private placement of convertible debentures and fall under Section 42 (Private Placement) and Section 62(1)(c) (conversion into equity). Many companies skip filing Form PAS-3 or don't maintain the required record of offers.
• Tip: Issue OCDs only after Board and Special Resolutions, ensure compliance with Rule 14 of Companies (Prospectus and Allotment of Securities) Rules, 2014, and maintain a record of private placement offers in Form PAS-5.

Ignoring Valuation Requirements

• Mistake: Not obtaining a proper valuation report at the time of issue or conversion.
• Explanation: Both under the Companies Act and FEMA, conversion of OCDs into equity must be based on a valuation done by a registered valuer (Companies Act) or SEBI-registered merchant banker (FEMA) or Chartered Accountant as the case may be.
• Tip: Obtain and preserve valuation reports at the time of issuance and at the time of conversion. For foreign investors, valuation must be not less than fair market value (FMV) as per FEMA norms.

Omission of Clear Terms of Conversion

• Mistake: Vague or absent clauses related to conversion in the Debenture Subscription Agreement (DSA) or Debenture Trust Deed (DTD).
• Explanation: RBI and ROC require that the terms of conversions such as time frame, ratio, triggers, and optionality-be clearly mentioned in the issue documents.
• Tip: Include detailed and unambiguous conversion terms in the offer letter, DSA, and trust deed. Ambiguity can lead to non-recognition of equity at conversion and rejection of FC-GPR.

Failure to Appoint Debenture Trustee or Create Charge

• Mistake: Skipping the appointment of a debenture trustee or failing to create a charge on assets (where applicable).
• Explanation: As per Rule 18 of Companies (Share Capital and Debentures) Rules, 2014, if the company issues secured debentures with maturity beyond 18 months, a trustee and charge registration (Form CHG-1) is mandatory.
• Tip: Ensure timely appointment of a trustee and registration of charges with ROC for secured OCDs.

Delays or Defaults in Reporting to Regulatory Authorities

• Mistake: Missing deadlines for filings like FC-GPR, Form MGT-14, PAS-3, or DIR-12 (if directors change due to investment terms).
• Explanation: Non-filing can attract penalties and disqualifications under the Companies Act and FEMA.
• Tip: Maintain a compliance calendar and track all regulatory filings post-issuance and at the time of conversion.

Lack of Board and Shareholder Approvals for Conversion

• Mistake: Assuming conversion is automatic and does not require further corporate action.
• Explanation: Even if conversion is optional and contractually agreed upon, a Board Resolution and sometimes a Shareholder Resolution under Section 62(1)(c) are required at the time of actual conversion
• Tip: Pass necessary resolutions at the time of conversion and file MGT-14 with ROC wherever applicable.

Not Aligning Conversion with Authorized Capital

• Mistake: Issuing or converting OCDs without ensuring sufficient authorized equity share capital.
• Explanation: ROC will not accept conversion if authorized capital is inadequate.
• Tip: Check and increase the authorized share capital in advance to avoid delays in FC-GPR and ROC filings.

Conclusion

Optionally Convertible Debentures are powerful financial instruments-but they require careful handling. Their hybrid nature means you must walk a tightrope between debt and equity regulations, domestic company law, and FEMA/RBI regulations.Many companies, especially startups and unlisted entities, fall into avoidable traps due to ignorance or oversight. A proactive approach to legal structuring, compliance planning, and timely filings can save time, money, and future litigation.

Call to Action

If you're planning to issue OCDs or have already done so and want to ensure full compliance, consult a qualified Company Secretary or legal advisor to audit your documents and filings. Reach out to professionals who understand the nuances of cross-border and hybrid instruments.

Let your funding strategy not become a compliance headache-plan ahead, structure smartly, and execute compliantly.

Disclaimer: This article provides general information existing at the time of preparation and we take no responsibility to update it with the subsequent changes in the law. The article is intended as a news update and Affluence Advisory neither assumes nor accepts any responsibility for any loss arising to any person acting or refraining from acting as a result of any material contained in this article. It is recommended that professional advice be taken based on specific facts and circumstances. This article does not substitute the need to refer to the original pronouncement.